LivingGLP1
Study S001983

Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors

ClinicalTrials.gov record

Registration

Registration
NCT07257484
Study type
INTERVENTIONAL
Phase
PHASE4
Masking
NONE
Status
RECRUITING
Enrollment
30
Start
2026-06-08
Primary completion
2027-12-03
Lead sponsor
Weill Medical College of Cornell University
Conditions
Obesity (Disorder); Breast Cancer
Interventions
DRUG:Tirzepatide
Results posted
FALSE
Individual participant data sharing
NO
Secondary identifiers
NIH:KL2TR002385

Registered primary outcomes

  • Percentage of participants completing week 24 visit with all required assessments [24 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.